What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cytokine
Paul W. Noble focuses on Idiopathic pulmonary fibrosis, Internal medicine, Immunology, Cell biology and Pulmonary fibrosis.
His research in Idiopathic pulmonary fibrosis intersects with topics in Physical therapy, Quality of life and Clinical trial.
His studies deal with areas such as Gastroenterology and Surgery as well as Internal medicine.
Paul W. Noble has researched Gastroenterology in several fields, including Nintedanib and Pirfenidone.
His studies in Immunology integrate themes in fields like Fibrosis, Cancer research and Lung.
His studies deal with areas such as Alveolar cells, Stromal cell, Biochemistry and Cellular differentiation as well as Cell biology.
His most cited work include:
- American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias (3012 citations)
- Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis (2009 citations)
- A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis (1848 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Idiopathic pulmonary fibrosis, Internal medicine, Immunology, Pathology and Pirfenidone.
His Idiopathic pulmonary fibrosis research incorporates themes from Adverse effect, Pulmonary fibrosis, Clinical trial and Interstitial lung disease.
His Internal medicine research includes themes of Gastroenterology and Surgery.
Paul W. Noble combines subjects such as Lung injury, Macrophage and Cell biology with his study of Immunology.
His Pirfenidone research integrates issues from Nintedanib and Cardiology.
His biological study spans a wide range of topics, including Molecular biology and Cytokine.
He most often published in these fields:
- Idiopathic pulmonary fibrosis (44.98%)
- Internal medicine (28.62%)
- Immunology (25.28%)
What were the highlights of his more recent work (between 2015-2021)?
- Idiopathic pulmonary fibrosis (44.98%)
- Internal medicine (28.62%)
- Pirfenidone (20.45%)
In recent papers he was focusing on the following fields of study:
Paul W. Noble spends much of his time researching Idiopathic pulmonary fibrosis, Internal medicine, Pirfenidone, Lung and Pulmonary fibrosis.
His research in Idiopathic pulmonary fibrosis intersects with topics in Epithelium, Vital capacity, Surgery, Pulmonary function testing and Interstitial lung disease.
Much of his study explores Internal medicine relationship to Gastroenterology.
His research integrates issues of Physiology, Discontinuation, Lung function and Cardiology in his study of Pirfenidone.
The various areas that Paul W. Noble examines in his Lung study include Cancer research, Stem cell, Immunology and Transcriptome.
His Pulmonary fibrosis research focuses on subjects like Lung injury, which are linked to Lung fibrosis.
Between 2015 and 2021, his most popular works were:
- Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials (213 citations)
- Single-Cell Deconvolution of Fibroblast Heterogeneity in Mouse Pulmonary Fibrosis. (171 citations)
- Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis (131 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cytokine
His primary areas of study are Idiopathic pulmonary fibrosis, Lung, Pulmonary fibrosis, Fibrosis and Internal medicine.
His research ties Disease and Idiopathic pulmonary fibrosis together.
His Pulmonary fibrosis study incorporates themes from Fibroblast, Lung injury and Immunology.
His Fibrosis study combines topics from a wide range of disciplines, such as Cancer research, Glycosaminoglycan and Hyaluronan Synthase 2.
In his research on the topic of Internal medicine, Vital capacity and Interstitial lung disease is strongly related with Surgery.
His study in Pathology is interdisciplinary in nature, drawing from both Bronchoalveolar lavage and Stem cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
